TRPM2 and cancer: TRPM2 expression in cancer cells was mostly reported to correlate with poor prognosis, as shown in neuroblastoma, squamous cells carcinoma, T-cell leukemia, breast, gastric, lung, pancreatic and prostate cancer cell lines and in patient samples.